PubRank

Robert M Merion

Author PubWeight™ 116.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003 10.11
2 Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003 8.47
3 A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009 4.45
4 Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007 3.69
5 Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002 3.42
6 Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007 2.72
7 Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005 2.64
8 Expanded criteria donors for kidney transplantation. Am J Transplant 2003 2.25
9 Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008 2.24
10 Improving liver allocation: MELD and PELD. Am J Transplant 2004 2.14
11 Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011 2.01
12 Racial and ethnic disparities in access to liver transplantation. Liver Transpl 2010 1.94
13 Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004 1.92
14 Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004 1.90
15 Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology 2009 1.84
16 Re-weighting the model for end-stage liver disease score components. Gastroenterology 2008 1.83
17 Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol 2008 1.76
18 Serum sodium and survival benefit of liver transplantation. Liver Transpl 2015 1.75
19 Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant 2004 1.72
20 Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007 1.69
21 Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2011 1.59
22 Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant 2012 1.55
23 Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005 1.48
24 Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation 2014 1.45
25 Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002 1.44
26 Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010 1.42
27 Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 2007 1.31
28 Simulating the allocation of organs for transplantation. Health Care Manag Sci 2004 1.31
29 Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma 2005 1.22
30 Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002 1.21
31 Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2005 1.20
32 End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology 2011 1.19
33 Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl 2004 1.19
34 The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003 1.14
35 Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation 2005 1.10
36 Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation 2002 1.09
37 Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 2011 1.09
38 Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg 2008 1.09
39 Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl 2009 1.06
40 Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol 2013 1.04
41 Selection of pediatric candidates under the PELD system. Liver Transpl 2004 1.01
42 Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant 2005 1.00
43 Educational web-based intervention for high school students to increase knowledge and promote positive attitudes toward organ donation. Health Educ Behav 2006 1.00
44 Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol 2013 0.99
45 Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant 2003 0.99
46 Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation 2007 0.99
47 Gender imbalance in living donor renal transplantation. Transplantation 2002 0.97
48 Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl 2003 0.95
49 Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004 0.91
50 Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005 0.91
51 Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl 2013 0.91
52 Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci 2011 0.88
53 Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002 0.87
54 Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure. Liver Transpl 2013 0.86
55 Liver transplantation in children with metabolic disorders in the United States. Am J Transplant 2003 0.85
56 Development and current status of ECD kidney transplantation. Clin Transpl 2005 0.84
57 Liver and intestine transplantation. Am J Transplant 2003 0.83
58 Variation in access to the liver transplant waiting list in the United States. Transplantation 2014 0.83
59 Liver transplantation for status 1: the consequences of good intentions. Liver Transpl 2007 0.83
60 Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg 2015 0.82
61 Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era. Dig Dis Sci 2014 0.80
62 Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex. Transplantation 2014 0.80
63 Hospitalization patterns before and after liver transplantation. Transplantation 2007 0.79
64 Extracorporeal support of the non-heart-beating organ donor. Transplantation 2002 0.79
65 Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Liver Transpl 2012 0.79
66 Organ donation and transplantation trends in the USA, 2003. Am J Transplant 2004 0.79
67 Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study. Transplantation 2016 0.79
68 National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation. Transplantation 2016 0.78
69 Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis 2003 0.77
70 Changes in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Liver Transpl 2015 0.77
71 Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant 2003 0.77
72 Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience. Indian J Pediatr 2007 0.77
73 Basiliximab in pediatric liver transplantation: a pharmacokinetic-derived dosing algorithm. Pediatr Transplant 2002 0.76
74 Evaluation of pancreatic allograft dysfunction by laparoscopic biopsy. Transplantation 2002 0.76
75 Are we ready for marginal hepatitis B core antibody-positive living liver donors? Liver Transpl 2003 0.75
76 Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Transplantation 2016 0.75
77 The angel is in the details. J Health Polit Policy Law 2011 0.75
78 It is time to look inward. Liver Transpl 2011 0.75
79 "Doc, should I accept this offer or not?". Liver Transpl 2004 0.75
80 Physician, heal thyself, but do not fly thyself. Liver Transpl 2010 0.75
81 Prevalence and Predictors of Patient-Reported Long-Term Mental and Physical Health After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Transplantation 2017 0.75
82 Living donor kidney transplantation at the University of Michigan. Clin Transpl 2011 0.75
83 HLA Amino Acid Polymorphisms and Kidney Allograft Survival. Transplantation 2017 0.75
84 Trends in cadaveric organ donation in the United States: 1990-1999. Clin Transpl 2002 0.75
85 Hepatic hemodynamics and portal flow modulation: The A2ALL experience. Transplantation 2017 0.75